• A single shot of Pfizer and BioNTech's COVID-19 vaccine reduces the risk of infection by 70%, the first real-world UK data suggests

    3 days ago - By Business Insider

    Medical assistant April Massaro gives a first dose of Pfizer BioNTech's COVID-19 vaccine to nurse Alice Fallago at Desert Valley Hospital on Thursday, December 17, 2020 in Victorville, California.
    Irfan Khan / Los Angeles Times via Getty Images
    One shot of Pfizer and BioNTech's vaccine reduced the risk of coronavirus infection by 70% in a UK study.
    The COVID-19 vaccine's protection increased to 85% in those who got two shots.
    The data showed Pfizer's vaccine worked against a mutated variant found in the UK and US, B.1.1.7.
    Visit the Business section of Insider for more stories .
    Pfizer and...
    Read more ...

     

  • Israel planning to reopen amid rising COVID vaccinations

    Israel planning to reopen amid rising COVID vaccinations

    3 days ago - By Travel and Tourworld

    In light of nearly 4.3 million people receiving at least one shot of a COVID-19 vaccine, Israel has started to prepare for reopening its economy once again. The domestic tourism sector is gradually witnessing a return as locals return to cultural events, mall shopping, museums and gyms. Rural accommodation has now been joined by hotels in opening under coronavirus restrictions.
    The exit plan has been created based on the purple and green badge scheme. Entry to hotels, cultural and sports events, gyms and studios, swimming pools and places of worship is allowed only to green badge holders...
    Read more ...

     

  • People in France, Germany, and the UK are turning down the AstraZeneca vaccine because they want the Pfizer one instead, reports say

    3 days ago - By Business Insider

    A box containing vials of the AstraZeneca COVID-19 vaccine on the start of a vaccination campaign for health workers in France on February 6.
    ALAIN JOCARD/AFP via Getty Images
    During vaccine rollouts in France, Germany, and the UK, some are insisting on a particular shot.
    In Europe, officials are struggling to give out AstraZeneca's jab, and cite concerns about performance.
    In the UK, reports are mixed. The Washington Post suggested that some prefer the AstraZeneca vaccine, calling it the "English" one.
    Visit the Business section of Insider for more stories .
    People receiving vaccines in...
    Read more ...